20-F: SQM Reports Fiscal Year 2024 Results Amidst Lithium Market Volatility

Sentiment:

Annual Results


SQM's 20-F filing reveals a year of mixed performance, with strong sales volumes offset by significant price declines in key markets, particularly lithium, and ongoing legal and regulatory challenges.

Worse than expectedThe company's revenue, gross profit, and net income decreased significantly in 2024 compared to 2023.The average realized price of lithium decreased by 64%.

Summary

  • SQM's 20-F filing for the fiscal year ended December 31, 2024, provides a comprehensive overview of the company's performance and financial position.
  • The company experienced a decrease in revenues by 39.4% to US$4,528.8 million, compared to US$7,467.5 million in 2023.
  • Gross profit decreased by 56.8% to US$1,327.1 million, representing 29.3% of revenues, down from 41.2% in the previous year.
  • The company reported a net loss attributable to controlling interests of US$685.1 million, a stark contrast to the US$923.2 million profit in 2023.
  • Lithium and derivatives revenues saw a significant decline of 56.7%, while sales volumes increased by 21% to 205 thousand metric tons.
  • The average realized price of lithium dropped by 64% to US$10,936 per ton.
  • Specialty Plant Nutrition revenues increased slightly by 3%, with sales volumes up by 17% but average prices down by 12%.
  • Iodine and derivatives revenues increased by 8.5%, driven by an 11% increase in sales volumes.
  • Potassium revenues decreased by 3.0%, with sales volumes up by 28% but average prices down by 24.2%.
  • The company is actively managing its capital structure and liquidity, with US$2.5 billion in cash and cash equivalents and time deposits as of December 31, 2024.
  • SQM's Net Financial Debt to Adjusted EBITDA ratio was 1.6x as of December 31, 2024.
  • The company is facing ongoing legal and regulatory challenges, including tax claims from the Chilean Internal Revenue Service and an investigation by the SEC.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While sales volumes increased in some areas, the significant decline in lithium prices and overall profitability suggests a neutral to slightly negative outlook.

Positives

  • Sales volumes for lithium and derivatives increased by 21% in 2024.
  • Specialty Plant Nutrition sales volumes grew by approximately 17% in 2024.
  • Iodine and derivatives revenues increased by 8.5%, driven by an 11% increase in sales volumes.
  • Potassium sales volumes grew by more than 28% in 2024.
  • The company maintains a strong liquidity position with US$2.5 billion in cash and cash equivalents and time deposits.

Negatives

  • The company reported a net loss attributable to controlling interests of US$685.1 million in 2024.
  • The average realized price of lithium decreased by 64% to US$10,936 per ton.
  • The company is facing ongoing legal and regulatory challenges, including tax claims from the Chilean Internal Revenue Service and an investigation by the SEC.

Risks

  • Volatility in lithium, fertilizer, and other chemical prices could affect the company's financial performance.
  • Global shipping constraints could impact the company's ability to deliver products to customers.
  • Economic conditions in emerging markets could affect the company's sales and expansion strategy.
  • Increased competition in the lithium, iodine, and potassium nitrate markets could adversely affect prices.
  • The company's capital expenditure program is subject to significant risks and uncertainties.
  • Environmental laws and regulations could expose the company to higher costs and liabilities.
  • A potential change of control of the company could have a material adverse effect on its business.
  • The National Lithium Strategy in Chile has created uncertainty in the lithium industry.
  • The company is exposed to political risks in Chile and uncertainty surrounding upcoming elections.

Future Outlook

The company expects lithium sales volumes to increase by approximately 15% in 2025, but anticipates that the average realized price will be lower than in 2024.

Industry Context

The announcement reflects the broader trends in the lithium market, including increased production capacity and fluctuating prices due to global economic conditions and demand for electric vehicles.

Comparison to Industry Standards

  • The document does not provide enough information to compare SQM's results to specific industry standards or competitors.
  • A more detailed analysis would require comparing SQM's production costs, sales volumes, and profitability metrics to those of companies like Albemarle, Ganfeng Lithium, and Livent.

Legal Proceedings

  • The company is involved in ongoing tax claims with the Chilean Internal Revenue Service.
  • The company is subject to an investigation by the SEC regarding potential violations of the Foreign Corrupt Practices Act.

Stakeholder Impact

  • Shareholders may be concerned about the decline in profitability and the ongoing legal and regulatory challenges.
  • Employees may be affected by potential changes in operations or cost-cutting measures.
  • Customers may benefit from increased production capacity and potentially lower prices.

Next Steps

  • The company will continue to implement its capital expenditure program.
  • The company will continue to monitor and manage its financial risks.
  • The company will continue to cooperate with the SEC investigation.

Key Dates

DateDescription
1968-06-17Sociedad Qumica y Minera de Chile S.A. was constituted.
1993-09-20SQM's ADRs began trading on the NYSE.
2024-04-25Annual General Shareholders Meeting held, Board of Directors elected.
2024-05-31SQM and Codelco entered into a partnership agreement for the joint exploitation of the Salar de Atacama.
2024-12-31End of fiscal year 2024.
2025-01-284.38% Notes due 2025 US$250 million maturity date.
2025-04-23Date of this 20-F filing.

Keywords

lithium, SQM, potassium, iodine, financial results, mining, derivatives, fertilizers, Salar de Atacama, Chile

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.